Daniel Bloch

Publications

• Safety issues in the development of treatments for osteoarthritis: recommendations of the Safety Considerations Working Group. Strand V, Bloch DA, Leff R, Peloso PM, Simon LS. Osteoarthritis Cartilage. 2011; 19 (5): 493-9
• Sham or scam: a critical assessment of recent vertebroplasty trials. Frankel B, Bloch DA. Neurosurgery. 2010; 67 (2): E521
• A combined superiority and non-inferiority approach to multiple endpoints in clinical trials. Bloch DA, Lai TL, Su Z, Tubert-Bitter P. Stat Med. 2007; 26 (6): 1193-207
• Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis. Popat RA, Tanner CM, van den Eeden SK, Bernstein AL, Bloch DA, Leimpeter A, McGuire V, Nelson LM. Amyotroph Lateral Scler. 2007; 8 (3): 157-63
• Iliac fixation inhibits migration of both suprarenal and infrarenal aortic endografts. Benharash P, Lee JT, Abilez OJ, Crabtree T, Bloch DA, Zarins CK. J Vasc Surg. 2007; 45 (2): 250-7
• Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. Sandborg C, Holmes TH, Lee T, Biederman K, Bloch DA, Emery H, McCurdy D, Mellins ED. J Rheumatol. 2006; 33 (11): 2322-9